Why ordered blood tests so often never get done
About one in three U.S. adults ages 18 to 65 say they avoid or delay a blood test. In everyday practice, that means a clinician can make a thoughtful order, anticipate an answer, and still never receive the data needed to guide care. The sample is never drawn, the result never returns, and the next decision is left hanging.
Laboratory testing informs roughly 70% of medical decisions, so a missed draw is not a minor administrative lapse. It can delay diagnosis, leave chronic disease monitoring incomplete, or push treatment changes further down the road. When a patient skips the test entirely, the gap is not just between visit and lab; it is between clinical suspicion and clinical action.
Patients also tend to experience follow-through as part of the physician encounter rather than as a separate laboratory task. When the process feels cumbersome, that friction can become part of how they judge the practice itself. In one 2022 online survey of more than 2,000 U.S. adults conducted by The Harris Poll on behalf of Tegria, 69% said they would consider switching providers for better services. Operational difficulty can affect trust faster than many practices expect.
Needle anxiety remains a central barrier, but it is only one part of the problem. Transportation, time away from work, difficulty finding a lab, uncertainty about preparation, and the hassle of making a second appointment all add layers of resistance. For some patients, a blood draw is uncomfortable; for others, the whole sequence surrounding it is exhausting.
Convenience failures begin before the needle comes out
The easiest way to lose a blood test is to make patients work too hard to complete it. A visit that ends with an order can still fail if the patient must then locate a site, schedule another slot, and navigate wait times or confusing instructions. Even motivated patients may stall when the next step is opaque.
Many organizations are expanding collection beyond traditional patient-service centers. Ambulatory, retail, and community settings can widen access, but only when the operational foundation is sound. Laboratory information-system integration, standardized collection protocols, specimen preparation, handling procedures, and chain-of-custody documentation all have to work together. Without that infrastructure, convenience becomes a slogan rather than a usable workflow.
Scheduling design matters just as much. Rigid appointment windows can turn a quick blood draw into a logistics problem, especially for people balancing work, caregiving, and transportation constraints. Open-access scheduling, self-scheduling, mobile check-in, and reminder outreach can reduce the friction that leads patients to postpone the task altogether.
A 2024 systematic review by Mazaheri Habibi and colleagues found that 10 of 16 studies reported significant reductions in outpatient no-show rates after open-access scheduling, although outcomes varied by setting and implementation. The finding does not solve every access problem, but it does show how much wasted effort can sit in the calendar itself. A lab order may be clinically simple; the path to completion often is not.
Needle fear still changes behavior
Fear of venipuncture can be strong enough to shape whether a patient shows up at all. A 2019 systematic review by McLenon and Rogers in the Journal of Advanced Nursing estimated needle fear at 20% to 50% among adolescents and 20% to 30% among young adults. Those numbers help explain why a routine blood test can trigger avoidance long before the patient reaches the lab chair.
Conversation alone does not always overcome that barrier. Patients may understand why the test matters and still defer it because the physical experience feels intolerable or because prior encounters were painful or distressing. For practices, the implication is straightforward: education is necessary, but it is not enough by itself.
For selected assays and validated workflows, capillary blood collection or micro-sampling may offer a less invasive alternative to venous collection. The key word is validated. Capillary and venous specimens are not interchangeable by default, and the correct option depends on the analyte, collection device, specimen handling, assay method, intended use, and the laboratory’s validation process.
Peer-reviewed research has shown clinical equivalence to conventional testing across a broad range of routine tests in some integrated microsample workflows. In other settings, standard venipuncture remains the right choice. Automated preparation in advanced microsample systems may also reduce manual handling and standardize pre-analytic steps, but the entire chain has to be validated end to end. For clinicians, the practical question is not whether a less invasive option exists somewhere; it is whether it exists for the specific test being ordered.
Patients are more likely to complete testing when the collection method fits their needs and the clinical workflow. A younger adult with strong needle anxiety may benefit from a different collection pathway than a patient whose test requires conventional venous sampling. The point is not to replace traditional phlebotomy across the board. The point is to remove an avoidable barrier when a safe, validated alternative exists.
Results communication can make or break follow-through
Completion does not end when the sample is collected. Delayed, hard-to-access, or poorly explained results can create a second failure point, especially if the patient is left unsure whether anything happened after the draw. In ambulatory care, failures to follow up on test results have been associated with delayed or missed diagnoses, making communication part of the diagnostic process rather than an afterthought.
A simple results pathway helps patients understand where they stand and what happens next. One accessible channel for test status and results is easier to navigate than multiple portals, phone calls, or unclear messages. Plain language matters here. Patients need to know not only what the result says, but what it means, whether any abnormal finding needs action, who will contact them, and when that contact should occur.
When communication is vague, patients can interpret silence as reassurance or, just as often, as neglect. Both are dangerous. A clear follow-up plan keeps the burden from falling entirely on patients to interpret a number, decide whether it matters, and guess when someone will call back.
Closing the gap requires shared ownership
The diagnostics system fails most often in the spaces between touchpoints. A patient may avoid a visit because of anxiety about the blood draw, or may complete the visit but never make it to the lab, or may finish the test and still not understand what happens next. Each step is small on its own. Together, they determine whether the order has any clinical value.
Providers cannot force adherence to blood testing. They can, however, reduce the number of reasons patients drop out. Easier scheduling, better access points, less invasive collection options where appropriate, and more transparent results communication all make completion more likely.
The bedside consequence is concrete: when testing is easier to complete, the clinician is more likely to get the information needed to diagnose, monitor, and treat. When it is not, the chart stays incomplete and the next decision is delayed.